Translate
Healthcare Data Intelligence: From Raw Data to Strategic Clarity
CURA transforms the healthcare industry's most complex, high-volume datasets into structured, validated intelligence — helping pharmaceutical companies, healthcare providers, and life sciences organizations make decisions with precision and confidence.
The Healthcare Data Challenge Every Organization Faces
Healthcare organizations are sitting on enormous volumes of data — clinical records, insurance claims, lab results, patient registries, prescription histories, device utilization logs, and public health surveillance data. Yet the vast majority of this data remains underutilized, siloed across incompatible systems, or buried in formats that resist analysis.
The cost of this intelligence gap is measured in missed market opportunities, delayed therapeutic development, suboptimal reimbursement strategies, and care delivery inefficiencies. CURA's Healthcare Data Intelligence service exists to close that gap — systematically, rigorously, and at scale.
We aggregate, validate, and structure healthcare data from over 500 curated sources and deliver it as analyst-ready intelligence designed for immediate strategic application.
Ethical De-identification
All analytical pipelines conform strictly to HIPAA Safe Harbor and SOC 2 Type II structures. Zero patient records are stored or exposed as PII.
Analytical Focus Areas
Medical Claims & Insurance Data Intelligence
Pharmacy and medical claims datasets contain some of the most granular, longitudinal insights available in healthcare. CURA processes both pharmacy claims and medical/surgical claims to deliver:
- •Disease prevalence and incidence mapping
- •Therapy adoption curves and treatment duration analysis
- •Line-of-therapy sequencing and switching patterns
- •Payer mix and reimbursement intelligence by geography
- •Procedure volume and site-of-care analytics
Electronic Health Record (EHR) Analytics
De-identified EHR data provides rich clinical context unavailable in claims alone. Our EHR analytics intelligence includes:
- •Comorbidity profiling and patient segmentation
- •Lab result pattern analysis and biomarker intelligence
- •Physician prescribing behavior by specialty, geography, and payer
- •Clinical outcome measurement and quality indicator benchmarking
- •Time-to-treatment and diagnosis delay analysis
Disease Burden & Epidemiological Intelligence
Understanding the true burden of disease — across geographies, patient segments, and time horizons — is foundational to pharmaceutical development, market access strategy, and public health planning. We deliver:
- •Global and regional disease prevalence and incidence estimates
- •Mortality and morbidity burden analysis
- •Unmet clinical need identification
- •Patient population sizing for indication planning
- •Disease progression modeling and natural history analysis
Treatment Pattern & Prescribing Intelligence
Prescribing behavior data reveals market dynamics that competitive intelligence alone cannot. Our treatment pattern intelligence covers:
- •First-line versus second-line therapy adoption rates
- •Off-label prescribing patterns by specialty
- •Combination therapy trends
- •Physician segmentation by prescribing volume and behavior
- •Geographic variation in treatment standards
Patient Journey Mapping
Understanding the full patient pathway from symptom onset to diagnosis, treatment initiation, and long-term management creates strategic opportunities at every touchpoint. We map patient journeys across:
- •Diagnosis delay and missed diagnosis analysis
- •Referral patterns and care coordination pathways
- •Treatment adherence and discontinuation rates
- •Post-treatment monitoring and follow-up patterns
Use Cases: How Healthcare Data Intelligence Creates Value
Market Access Strategy
A specialty pharma company used CURA's claims data intelligence to identify the optimal patient population for a new rheumatology asset — revealing that 34% of eligible patients were undertreated in secondary care settings, representing a significant untapped commercial opportunity.
Operational Benchmarking
A regional hospital network leveraged CURA's procedure utilization analytics to benchmark its service line performance against peer institutions — identifying $12M in annual operational efficiency opportunities across surgical services.
Product Development
A health insurance carrier used CURA's disease burden intelligence to redesign its diabetes management benefit package — reducing unnecessary ER utilization by 18% in the first plan year.
Data Sources & Quality Standards
CURA's healthcare data intelligence is derived from validated, licensed, and ethically sourced datasets.
All datasets are processed through our multi-layer validation framework, cross-referenced for consistency, and enriched with domain-expert annotation before delivery.
INTEGRATED DATASETS INVENTORY
Claims Databases
Commercial, Medicare, Medicaid, and multi-payer claims repositories
EHR Networks
De-identified records from integrated delivery networks and ambulatory care systems
Patient Registries
Disease-specific registries covering oncology, rare diseases, cardiovascular, neurology, and more
Public Health Databases
CDC, WHO, OECD Health Statistics, Global Burden of Disease datasets
Clinical Trial Registries
ClinicalTrials.gov, EU Clinical Trials Register, WHO ICTRP
Payer Formulary Data
Commercial, government, and Part D formulary intelligence
CMS.gov Live Provider Data
Using curated provider dataset. CMS live API requires specific dataset ID.
WHO Global Health Indicators
Using curated WHO indicator dataset. Live API requires specific indicator code.
Frequently Asked Questions — Healthcare Data Intelligence
Is your healthcare data HIPAA-compliant?
Yes. All patient-level data handled by CURA is fully de-identified in compliance with HIPAA's Safe Harbor and Expert Determination de-identification standards. We do not handle personally identifiable health information (PHI) in any deliverable.
How current is your healthcare data?
Our core claims and EHR datasets are updated on a monthly cadence, with epidemiological and registry data refreshed quarterly. Regulatory and pipeline intelligence is updated in real time.
Can you deliver healthcare data specific to a therapeutic area or geography?
Yes. All intelligence deliverables are configurable by therapeutic area, indication, geography, care setting, patient segment, and payer type.
Deploy Analytical Intel with Institutional Assurance
Request de-identified patient population matrices and cohort analysis designed for custom drug licensing modeling.
